Structures by: Kreher D.
Total: 8
2-(4-tert-Butylphenyl)-5-[4-(3,3-diethoxy-propyn-1-yl)- phenyl]-1,3,4-oxadiazole
C25H28N2O3
Organic & biomolecular chemistry (2004) 2, 6 858-862
a=7.356(2)Å b=19.870(5)Å c=15.136(4)Å
α=90.00° β=91.37(1)° γ=90.00°
2-(4-tert-Butylphenyl)-5-[4-(5,5-diethoxy-1,3-pentadiyn-1-yl)- phenyl]-1,3,4-oxadiazole
C27H28N2O3
Organic & biomolecular chemistry (2004) 2, 6 858-862
a=14.835(5)Å b=6.161(1)Å c=25.549(3)Å
α=90.00° β=91.14(1)° γ=90.00°
{3-[5-(4-tert-Butylphenyl)-1,3,4-oxadiazol-2-yl]-phenyl}- propynal
C21H18N2O2
Organic & biomolecular chemistry (2004) 2, 6 858-862
a=11.945(2)Å b=6.183(1)Å c=23.460(5)Å
α=90.00° β=97.94(1)° γ=90.00°
2-(3-{4-[5-(4-tert-Butylphenyl)-1,3,4-oxadiazol-2-yl]-phenyl}- prop-2-ynylidene)-1,3-dithiole-4,5-dicarboxylic acid dimethyl ester
C28H24N2O5S2
Organic & biomolecular chemistry (2004) 2, 6 858-862
a=10.878(1)Å b=11.000(1)Å c=12.705(1)Å
α=114.866(10)° β=105.881(10)° γ=97.048(10)°
2-(4-tert-butylphenyl)-5-(4-(2-pyrazylethynyl)phenyl)-1,3,4- oxadiazole
C24H20N4O
Organic & Biomolecular Chemistry (2004) 2, 22 3363-3367
a=22.881(3)Å b=6.314(1)Å c=28.860(4)Å
α=90.00° β=109.86(1)° γ=90.00°
2-(4-tert-butylphenyl)-5-{4-(3-thienylethynyl)phenyl}- 1,3,4-oxadiazole
C24H20N2OS
Organic & Biomolecular Chemistry (2004) 2, 22 3363-3367
a=6.1665(5)Å b=6.9748(5)Å c=22.943(3)Å
α=83.55(1)° β=84.09(1)° γ=83.67(1)°
2-(4-tert-butylphenyl)-5-{4-(5-ethynyl-2-thienylethynyl)phenyl}- 1,3,4-oxadiazole
C26H20N2OS
Organic & Biomolecular Chemistry (2004) 2, 22 3363-3367
a=6.345(2)Å b=6.985(2)Å c=23.672(8)Å
α=94.24(1)° β=91.96(1)° γ=91.93(1)°
2-(4-tert-butylphenyl)-5-{5-(2-pyrazyl-ethynyl)-2-thienyl}- 1,3,4-oxadiazole, chloroform monosolvate
C22H18N4OS,CHCl3
Organic & Biomolecular Chemistry (2004) 2, 22 3363-3367
a=6.1798(4)Å b=26.851(8)Å c=13.650(1)Å
α=90.00° β=92.26(1)° γ=90.00°